Introduction
Resective surgery for the treatment of drug-resistant mesial temporolimbic epilepsy may be very effective, with an overall 66% complete seizure control. 1 However, resection of potentially functional structures such as the anterior temporal lobe, amygdala or hippocampus could lead to loss of function. Alternatives to resective surgical treatment of temporal epilepsy may take the approach of restorative surgery. Some cases of epilepsy may be viewed as a loss of GABAergic function, therefore continuous local delivery of GABA should permanently correct this.
We have previously shown that local delivery of GABA to the amygdala increases both the afterdischarge and the seizure thresholds of the amygdala kindled rats. 2 Other researchers have used genetically engineered cells that released GABA to impair the development of kindling. 3 It has been shown that precursor cells form the embryonic median ganglionic eminence (MGE), an embryonic source of GABAergic cells, when injected into adult mammalian brain tissue, are able to disperse and differentiate into neurons in multiple adult brain regions. One-third of these cells were stained with antibodies against GABA. 4 In a subsequent study, these cells were shown to migrate throughout the brain when injected in postnatal animals, express GABAergic phenotype and establish inhibitory synaptic connections with host neurons. 5 The purpose of this study was to determine the anticonvulsant effect of the local injection of MGE cells in the amygdala in a temporolimbic kindling model in the rat. As controls, we injected fibroblasts.
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Background: Intracerebral infusion of anticonvulsant agent secreting cells has proven to raise the threshold for seizure generation in epileptogenic areas. Median ganglionic eminence (MGE) is the main embryonic region where future GABAergic cells originate. Here we report the results of intraamygdaline grafting of MGE cells versus fibroblasts in a piriform cortex kindling model of epilepsy in the rat. Material and methods: Rats were implanted with an electrode in the left piriform cortex and subjected to infusion at the left basolateral amygdala of cells obtained from the MGE of embryos or fibroblasts. Some of the donor cells were obtained from transgenic rats expressing the green fluorescent protein (GFP). Seizure and neurologic behavior were recorded, and inmunohistochemical and ultrastructural studies were carried out. Results: Cells obtained from the embryonic MGE elevated both the afterdischarge and the seizure threshold progressively, being significant 3 weeks after their injection. On the contrary, fibroblasts injected into the amygdala raised the seizure thresholds the first week, the effect weaning during the following weeks. Fibroblasts and MGE cells were shown at the injected amygdala. No behavioral side effects were recorded in either experimental group. Conclusion: MGE cells implanted at the amygdala may control the focal component of temporolimbic seizures. This effect may be mediated by local release of GABA.
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Methods

Animals
For the kindling experiments, we used adult male Wistar rats, bred under standard colony conditions in the facilities of the Research Centre of the University General Hospital in Valencia (Spain). Fibroblasts and embryonic median ganglionic eminence cells (MGE) were obtained either from wild type or from transgenic rats expressing the green fluorescent protein (GFP). The experimental protocols were approved by the corresponding institutional animal care committee, in compliance with current European directives for animal experimentation (86/609/ECC) and with those set by the Valencian Community Government.
Kindling procedure
Animals weighing 270-310 g were stereotactically implanted with a bipolar electrode at the left pyriform cortex, and a cannula directed to the left basolateral amygdala. Animals were anaesthetised with an intraperitoneal (i.p.) injection of a mixture of ketamine (100 mg/kg), diazepam (8 mg/kg) and atropine sulphate (0.4 mg/kg). The electrode consisted of a twisted pair of 0.2 mm diameter Teflon-coated stainless steel wires (Advent Research Materials, Suffolk, England), the tips of which were exposed by 0.2 mm and separated by 0.5 mm, and then placed at the following coordinates: 0.8 mm posterior, 4.9 mm left, and 8.8 mm ventral from the bregma. 6 The cannula was made of stainless steel (0.7 mm outer diameter, 15 mm long), and an appropriate stylet was put in place. The tip of the cannula was stereotactically implanted at a distance 5 mm from the basolateral amygdala, at the following coordinates: 2.2 mm posterior, 4.8 mm left, and 3.5 mm ventral from the bregma. 6 Four symmetrical, chlorinated, silver recording electrodes were implanted into the epidural space (two frontal and two occipital). In addition, an indifferent electrode was placed under the skin of the neck. All electrodes were connected to a 7-pin miniature connector. The cannula, electrodes and connector were fixed to the skull vault with dental acrylic cement, and the skin was closed with silk suture at both ends of the incision. After surgery, animals were individually caged. A standard kindling procedure commenced 10 days after surgery, which involved daily stimulation with a 1-s train of 50 Hz square wave pulses (1 ms duration and 500 mA amplitude), using a Grass S88 stimulator, until more than three consecutive stage 5 seizures 7 were provoked. At this point, the animal was considered fully kindled. The afterdischarge threshold (ADT) and seizure threshold (ST) were determined 3 days before implantation. This was done using a stepwise ascent method, 8 consisting of stimulation with a series of 1-s train of 50 Hz square wave, in pulses lasting 1 ms, separated by 1 min intervals. Current intensity began at an amplitude of 7 mA and was increased gradually, by 20% each step, to 500 mA, or until a behavioral seizure occurred. The amplitude reached when a seizure was produced was considered to be the seizure threshold (ST). Similarly, the lowest amplitude to elicit an afterdischarge of at least 5 s was considered to be the afterdischarge threshold (ADT). Thresholds were first measured on Tuesdays, 3 days before implantation, and this procedure was repeated over the following 2 days, and the mean of the three determinations was considered as the control threshold value. 9 
Implantation of cells
Once the animals were fully kindled, basal seizure readings were taken the 3 days just before implantation. The animals were anaesthetised once more with the same intraperitoneal injection mixture as previously described, in order to be implanted with either fibroblasts (n = 8) or cells from the MGE (n = 8).
MGE cells were obtained from embryonic day 14.5 embryos of homozygote transgenic rats ([Wistar-TgN(CAG-GFP)184ys]) with constitutive expression of green fluorescent protein (eGFP) (Rat Resource and Research Center, University of Missouri, USA). Parents were paired on Thursdays 2 weeks before implantation. We used one mother for each three implants (6-8 fetuses per mother, about 2.5 fetuses per implant).
The lateral ventricular wall was dissected under magnifying loupes. The tissue from the area near the sulcus between MGE and the lateral ganglionic eminence was discarded in order to avoid contamination. The explant was mechanically dissociated, digested with DNase I and centrifuged, and a suspension of about 100,000 cells per ml of DMEM was prepared. The fluorescence of such cells was checked with a fluorescence microscope prior to the injection. 1 ml of such suspension was injected to 8 fully kindled rats with a Hamilton syringe through the 21G cannula at the left basolateral amygdala, at the coordinates 2 mm posterior, 4.8 mm left and 8.5 mm ventral from Bregma. 6 Fibroblasts were obtained from adult rat muscle. The muscle was dissected and triturated with collagenase II (4 mg/ml) in PBS (phosphate buffered saline), obtaining a cell suspension which was adjusted to a cell density of 1 Â 10 5 viable cells/cm 2 and seeded in plates. Fibroblasts were cultured as monolayers in DMEM, 10% PBS, streptomycin + penicillin (100 mg/ml) and amphotericin (100 mg/ ml) (Gibco; http://www.invitrogen.com). Cultures were incubated in a humidified atmosphere with 5% CO 2 in air at 37 8C. Cell transfer was performed by enzymatic dissociation with 0.25% trypsin in PBS (Gibco). Counting was made with a Bü rker chamber, and 1 ml containing 100,000 cells was injected through the cannula. MGE cells and fibroblasts showed the appropriate in vitro markers Vimentin for fibroblasts and Tuj1 (class III b-tubulin) and NeuN (Neuronal Nuclei) for MGE cells.
Experiments
The anticonvulsant effect determination began on the third day after implantation. It was determined at the same time each day over a 5-weekday period (Monday to Friday) during 3 weeks. This was done through stimulation of the left pyriform cortex with the same parameters as in the kindling process in order to elicit a seizure (1-s train of 50 Hz square wave pulses, 1 ms duration and 500 mA amplitude). The parameters measured were ADT, ST and Racine's seizure stage. 7 The ADT and the ST were measured using the stepwise ascent method described in the previous section. Neurological side effects were tested immediately prior to stimulation by means of the following scales of ataxia and sedation:
10 Ataxia: 0 = absent, 1 = slight ataxia in hind legs, 2 = more pronounced ataxia with dragging of hind legs, 3 = further increase of ataxia and more pronounced dragging of hind legs, 4 = marked ataxia and loss of balance during forward locomotion, 5 = considerably marked ataxia with frequent loss of balance, 6 = permanent loss of righting reflex; sedation: 0 = absent, 1 = slightly reduced forward locomotion, 2 = reduced locomotion with rest periods between periods of locomotion, 3 = reduced locomotion with more frequent rest periods, 4 = no forward locomotion and the animal sits still with closed eyes.
Immunohistochemical study
Once the experiments were completed, animals were sacrificed with an intraperitoneal injection of pentobarbital. The appropriate position of the electrode at the medial pyriform cortex was checked in every animal by the effect of the electrode tip after the removal of the electrode.
Animals were perfused with 4% paraformaldehyde, and after decapitation, their skulls were opened and the brains extracted. These were immersed into 0.1 M PBS at pH 7.4. The brains were cut in 100 mm thick coronal sections using a vibratome (Leica VT 1000S) and were serially collected in PBS.
GABA expressing cells were detected with a rabbit antibody against GABA at a dilution of 1:2500 (Sigma, St. Louis, MO). This primary antibody was detected with a Cy5-conjugated AffiniPure goat anti-rabbit secondary antibody at a dilution of 1:200 (Jackson InmunoResearch). For NeuN we used Chemicon mouse monoclonal IgG MAB377, at a concentration 1:100. For Tuj1 we used Covance PRB 435P, rabbit polyclonal IgG, at a concentration 1:250. For Vimentin, we used in culture mouse antivimentin DakoCytomation, concentration 1:200 and in tissue mouse monoclonal antivimentin clone V9, Sigma-Aldrich, concentration 1:200.
GFP+ cells were detected using a Leica FW 4000 fluorescence microscope, using GFP filters, with a maximum excitation of 480 nm and maximum emission of 507 nm. Images were digitally captured for analysis with a DFC480 digital camera and IM500/ FW4000 image manager software (Leica, Cambridge, UK) on a DM6000B microscope (Leica, Wetzlar, Germany).
Statistical analysis
Wilcoxon's signed-rank test for paired replicates 11 was used to calculate the significance of individual differences between seizure and toxicity parameters after the cell implantation and controls of the same animals before cell implantation. Statistical significance was considered when p < 0.0166, since we had to apply a Bonferroni correction. This correction was necessary because repeated comparisons were made three times in each group of animals. Median values of each week were compared to baseline values. Data were also analyzed with ANOVA for repeated measures (general linear model) and they confirmed the major findings, but this was not taken into account because the different measures contravened the conditions of normal distribution and similarity of variances.
Values are shown as median (range), unless otherwise specified.
Results
Results are summarized in Table 1 .
Results of MGE cells implantation
Results on epileptic activity
Animals which received an implant of MGE cells showed a delayed but progressive improvement in the seizure parameters over time (Fig. 1) . ADT and GST did not show any significant difference as compared with pre-implant controls on weeks 1 and 2. On week 3 both thresholds raised significantly (p = 0.008). Seizure intensity was class 5 whenever it was elicited. No signs of neurological side effects were recorded in any of the animals.
Survival and integration of implanted MGE cells
GFP+ cells were observed by immunofluorescence at the injection site in the left amygdala, many of them coexpressing GABA as revealed by anti-GABA immunostaining (Fig. 2 ), but were also seen migrating towards other brain areas, specifically, the 
Table 1
Effect on the seizure parameters recorded before (pre-implantation), and the 3 weeks after (days 3-7, 10-14 and 17-21) intra-amygdalar implantation of MGE cells or fibroblasts. Wilcoxon's signed-rank test with Bonferroni correction was used to calculate the significance of individual differences between median values of seizure thresholds of the 3 weeks post-implantation and the pre-implantation threshold. After implantation of MGE cells increases on ADT and GST were only significant compared with pre-implant controls on week 3 (p = 0.008). Animals which received an implant of fibroblasts showed a significant improvement in GST the first week (p = 0.008), but a progressive worsening was noticed in the following weeks. Each parameter is expressed as median (minimum, maximum). ADT, afterdischarge threshold; ADD, afterdischarge duration; GST, generalized seizure threshold; GSD, generalized seizure duration; SS, seizure severity (Racine's score). Significant results are marked in red. cortex (Fig. 3) and the ventricular walls, and the electrode site scar. Many of these cells showed morphological features of interneurons (Fig. 4) and expressed Tuj-1 (Fig. 5) and NeuN (neurofilament) markers.
Results of fibroblasts implantation
Results on epileptic activity
Animals which received an implant of fibroblasts showed an immediate improvement in the seizure parameters, but a progressive worsening was noticed in the following weeks (Fig. 6 ). Unlike animals with MGE cell grafts, GST recorded after fibroblast implantation showed an immediate increase, with some animals showing no seizures with stimuli up to 500 mA during the first week. This was reflected in a significant increase of GST during the first week. However, this effect decreased on the second week, only the GST being slightly above the controls, and disappeared on the third week.
Survival of implanted fibroblasts
Histological and immunohistochemical study of animals implanted with fibroblasts showed GFP+ and vimentin+ cells at the point of implantation in the amygdala, at the pyriform cortex around the electrode and at the ventricular walls.
Discussion
Grafting of inhibitory interneurons may be a promising alternative to surgically control epilepsy. Our results show the potential antiepileptic effect of the injection of GABAergic cell precursors obtained from the embryonic MGE. Our data show that such transplanted cells are able to increase the current intensity threshold to evoke both local afterdischarges and seizure generalization in an epilepsy model, showing graft survival and function in a pathologic environment. These data support the results obtained by other researchers using genetically modified GABA releasing cells, 3, 12 which have shown their ability to decrease the epileptogenic process of kindling. Previous studies 4 have shown that precursor cells obtained from the embryonic MGE and implanted into the brain of adult mice migrate up to 1.5 mm from the graft site and differentiate into neurons expressing GABA. Another study 5 has shown that these cells, when implanted into neonatal brain, are able to functionally integrate into local circuits, establishing afferent and efferent synaptic contacts and inducing spontaneous inhibitory postsynaptic currents (IPSC's) onto the host pyramidal neurons, which show a greater inhibitory activity than the contralateral controls. These cells show morphologic and inmmunohistochemical signs of maturation between 3 and 7 days after transplantation. Between 14 and 21 days after transplantation, the morphologic characteristics of mature cell become more evident. Moreover, these cells do not show evidence of extensive migration 3 days after grafting. The number of surviving cells stabilizes after 30 days. These features explain the progressive appearance of antiepileptic properties 2 weeks after implantation. MGE cells implanted onto neonatal brain in mice are not active until the fourth week, which coincides with the time required to observe cells with mature morphology. 5 The difference in species and in the age of the host may account for the difference in the time to maturation. According to the previously cited studies, the establishment of functional inhibitory synapses may explain the antiepileptic effect of the implanted cells. GABA bioavailability at the epileptogenic area may also account for the antiepileptic effect, as we have previously shown with local infusion of GABA using osmotic pumps. 2 Moreover, the effect of GABA infusion is also raising both ADT and GST, without any effect on the seizure severity once it has been triggered. GABA activity at the grafted site was confirmed by immunohistochemistry, since GFP+ MGE cells at the injection site at the amygdala were also GABA positive as revealed by anti-GABA immunostaining.
On the contrary, fibroblasts are very active raising ST immediately after transplantation, even to the point of complete seizure suppression. This effect is transient, decaying over the following weeks. This timeline, opposite to MGE cells, account for a direct effect of fibroblasts at the epileptogenic area which cannot be explained solely by a mechanic effect of the implant, since in that case the implant of MGE would have shown a similar effect. Fibroblasts may have either provoked a local inflammatory reaction, not visible at our histological analysis, or they may release an unidentified anticonvulsant factor. Other studies have used genetically engineered fibroblasts overexpressing adenosine, and they proved to be an effective anticonvulsant agent when injected locally. 13 Thus, the release of adenosine or other substances cannot be ruled out. Another possible explanation is a migration of the fibroblasts to the electrode tip during the first week, with a possible insulating effect, which could be later overcome by the repeated stimulation or by cell death. ADT and GST were determined once per day at 5 days per week. This may raise the concern about a possible increase of seizure thresholds because of accumulation of endogenous anticonvulsant mechanisms because of too frequent threshold determination. However, we have followed this protocol in other studies and have not recorded a significant increase in ADT or GST.
